Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02698683
Other study ID # 2015-LCSINS
Secondary ID
Status Completed
Phase N/A
First received February 22, 2016
Last updated February 29, 2016
Start date February 2014
Est. completion date January 2016

Study information

Verified date February 2016
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Observational

Clinical Trial Summary

Participants were classified as normal or malnourished according to anthropometric measures. Serum albumin and zinc were recovered on the 1st and 7th days of hospitalization. Lymphocyte count was also recorded on the 1st and 7th days.


Description:

The investigators enrolled 14 consecutive patients with sepsis. Patients were classified as normal or malnourished according to anthropometric measures. As an additional evaluation of nutritional status, serum albumin and zinc were recovered on the 1st and 7th days of hospitalization. Lymphocyte count was also recorded on the 1st and 7th days. Investigators correlated nutritional status with lymphocyte count and zinc dosage.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date January 2016
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 1 Month to 14 Years
Eligibility Inclusion Criteria:

- septic patients

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
lymphocyte count
lymphocyte count

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

References & Publications (1)

Delgado AF, Okay TS, Leone C, Nichols B, Del Negro GM, Vaz FA. Hospital malnutrition and inflammatory response in critically ill children and adolescents admitted to a tertiary intensive care unit. Clinics (Sao Paulo). 2008 Jun;63(3):357-62. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary presence of lymphopenia seven days Yes
See also
  Status Clinical Trial Phase
Terminated NCT02659800 - Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas Phase 1
Completed NCT00771810 - Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Phase 2
Completed NCT00477321 - Safety Study of IL-7 in HIV-infected Patients (Inspire) Phase 1
Completed NCT06368349 - Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
Completed NCT04910230 - Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19 N/A
Completed NCT04800731 - Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
Completed NCT04404608 - Etiology of Lymphopenia in Covid19 Infection
Recruiting NCT06181656 - Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Completed NCT05889169 - Stroke-induced Immunodepression in Neurorehabilitation
Withdrawn NCT01660347 - Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant N/A